nach oben

Japanese Journal of Ophthalmology

Erschienen in:

01.01.2014 | Review

Genetics of primary open angle glaucoma

verfasst von: Mitsuko Takamoto, Makoto Araie

Erschienen in: Japanese Journal of Ophthalmology | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Glaucoma is a neurodegenerative disease and one of the leading causes of irreversible blindness, affecting over 60 million people worldwide. At the present time, glaucoma is clinically defined, but the exact etiology is unknown. Genetic studies are one approach to identify the molecules and pathways involved in disease pathogenesis. Familial aggregation of primary open-angle glaucoma (POAG) has long been recognized, and the analysis of POAG families with a Mendelian inheritance form of this disease has been employed to identify multiple loci linked to them. Some causative genes, such as myocilin, optineurin and WD repeat domain 36, have been identified. However, most cases of POAG are considered to be a prevalent, multifactorial disorder. Several association studies have been conducted for candidate genes, and genome-wide association studies recently identified new susceptibility loci for POAG, namely, S1 RNA binding domain 1 region on chromosome 2p21, the caveolin 1 and caveolin 2 regions on 7q31, transmembrane and coiled-coil domain 1 region on 1q24, cyclin-dependent kinase inhibitor 2B antisense RNA on 9p21, the SIX1 and SIX6 regions on 14q24 and, possibly, the regulatory region of 8q22. Further analysis of clinical manifestations caused by specific genes and functional analysis of these genes will contribute to the development of new strategies for the diagnosis and treatment of POAG.

Kielczewski JL, Pease ME, Quigley HA. The effect of experimental glaucoma and optic nerve transection on amacrine cells in the rat retina. Invest Ophthalmol Vis Sci. 2005;46:3188–96.PubMedCentralPubMed

Jakobs TC, Libby RT, Ben Y, John SW, Masland RH. Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J Cell Biol. 2005;171:313–25.PubMed

Quigley HA, Addicks EM. Regional differences in the structure of the lamina cribrosa and their relation to glaucomatous optic nerve damage. Arch Ophthalmol. 1981;99:137–43.PubMed

Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262–7.PubMed

Allingham RR, Damji KF, Shields MB. Shields textbook of glaucoma. 6th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011.

Wolfs RC, Klaver CC, Ramrattan RS, van Duijn CM, Hofman A, de Jong PT. Genetic risk of primary open-angle glaucoma. Population-based familial aggregation study. Arch Ophthalmol. 1998;116:1640–5.PubMed

Teikari JM. Genetic factors in open-angle (simple and capsular) glaucoma. A population-based twin study. Acta Ophthalmol (Copenhagen). 1987;65:715–20.

Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA. 1991;266:369–74.PubMed

Racette L, Wilson MR, Zangwill LM, Weinreb RN. Sample PA primary open-angle glaucoma in blacks: a review. Surv Ophthalmol. 2003;48:295–313.PubMed

10.

Klein BE, Klein R, Sponsel WE, Franke T, Cantor LB, Martone J, et al. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology. 1992;99:1499–504.PubMed

11.

Coffey M, Reidy A, Wormald R, Xian WX, Wright L, Courtney P. Prevalence of glaucoma in the west of Ireland. Br J Ophthalmol. 1993;77:17–21.PubMed

12.

Rotchford AP, Kirwan JF, Muller MA, Johnson GJ, Roux P. Temba glaucoma study: a population-based cross-sectional survey in urban South Africa. Ophthalmology. 2003;110:376–82.PubMed

13.

Dielemans I, de Jong PT, Stolk R, Vingerling JR, Grobbee DE, Hofman A. Primary open-angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population. The Rotterdam Study. Ophthalmology. 1996;103:1271–5.PubMed

14.

Kim CS, Seong GJ, Lee NH, Song KC. Prevalence of primary open-angle glaucoma in central South Korea the Namil study. Ophthalmology. 2011;118:1024–30.PubMed

15.

Iwase A, Suzuki Y, Araie M, Yamamoto T, Abe H, Shirato S, et al. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology. 2004;111:1641–8.PubMed

16.

Rudnicka AR, Mt-Isa S, Owen CG, Cook DG, Ashby D. Variations in primary open-angle glaucoma prevalence by age, gender, and race: a Bayesian meta-analysis. Invest Ophthalmol Vis Sci. 2006;47:4254–61.PubMed

17.

Coleman AL, Miglior S. Risk factors for glaucoma onset and progression. Surv Ophthalmol. 2008;53[Suppl 1]:S3–10.PubMed

18.

Boland MV, Quigley HA. Risk factors and open-angle glaucoma: classification and application. J Glaucoma. 2007;16:406–18.PubMed

19.

Chihara E. Myopia and diabetes mellitus as modificatory factors of glaucomatous optic neuropathy. Jpn J Ophthalmol. 2013. doi:10.1007/s10384-013-0267-3

20.

Kim M, Kim TW, Park KH, Kim JM. Risk factors for primary open-angle glaucoma in South Korea: the Namil study. Jpn J Ophthalmol. 2012;56:324–9.PubMed

21.

Fan BJ, Wang DY, Lam DS, Pang CP. Gene mapping for primary open angle glaucoma. Clin Biochem. 2006;39:249–58.PubMed

22.

Baird PN, Foote SJ, Mackey DA, Craig J, Speed TP, Bureau A. Evidence for a novel glaucoma locus at chromosome 3p21–22. Hum Genet. 2005;117:249–57.PubMed

23.

Pang CP, Fan BJ, Canlas O, Wang DY, Dubois S, Tam PO, et al. A genome-wide scan maps a novel juvenile-onset primary open angle glaucoma locus to chromosome 5q. Mol Vis. 2006;12:85–92.PubMed

24.

Wang DY, Fan BJ, Chua JK, Tam PO, Leung CK, Lam DS, et al. A genome-wide scan maps a novel juvenile-onset primary open-angle glaucoma locus to 15q. Invest Ophthalmol Vis Sci. 2006;47:5315–21.PubMed

25.

Wiggs JL, Allingham RR, Hossain A, Kern J, Auguste J, DelBono EA, et al. Genome-wide scan for adult onset primary open angle glaucoma. Hum Mol Genet. 2000;9:1109–17.PubMed

26.

Fingert JH, Robin AL, Stone JL, Roos BR, Davis LK, Scheetz TE, et al. Copy number variations on chromosome 12q14 in patients with normal tension glaucoma. Hum Mol Genet. 2011;20:2482–94.PubMed

27.

Stone EM, Fingert JH, Alward WL, Nguyen TD, Polansky JR, Sunden SL, et al. Identification of a gene that causes primary open angle glaucoma. Science. 1997;275:668–70.PubMed

28.

Rezaie T, Child A, Hitchings R, Brice G, Miller L, Coca-Prados M, et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science. 2002;295:1077–9.PubMed

29.

Monemi S, Spaeth G, DaSilva A, Popinchalk S, Ilitchev E, Liebmann J, et al. Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1. Hum Mol Genet. 2005;14:725–33.PubMed

30.

Pasutto F, Matsumoto T, Mardin CY, Sticht H, Brandstatter JH, Michels-Rautenstrauss K, et al. Heterozygous NTF4 mutations impairing neurotrophin-4 signaling in patients with primary open-angle glaucoma. Am J Hum Genet. 2009;85:447–56.PubMedCentralPubMed

31.

Sheffield VC, Stone EM, Alward WL, Drack AV, Johnson AT, Streb LM, et al. Genetic linkage of familial open angle glaucoma to chromosome 1q21–q31. Nat Genet. 1993;4:47–50.PubMed

32.

Wiggs JL, Del Bono EA, Schuman JS, Hutchinson BT, Walton DS. Clinical features of five pedigrees genetically linked to the juvenile glaucoma locus on chromosome 1q21–q31. Ophthalmology. 1995;102:1782–9.PubMed

33.

Richards JE, Lichter PR, Boehnke M, Uro JL, Torrez D, Wong D, et al. Mapping of a gene for autosomal dominant juvenile-onset open-angle glaucoma to chromosome Iq. Am J Hum Genet. 1994;54:62–70.PubMedCentralPubMed

34.

Wiggs JL, Haines JL, Paglinauan C, Fine A, Sporn C, Lou D. Genetic linkage of autosomal dominant juvenile glaucoma to 1q21–q31 in three affected pedigrees. Genomics. 1994;21:299–303.PubMed

35.

Meyer A, Valtot F, Bechetoille A, Rouland JF, Dascotte JC, Ferec C, et al. Linkage between juvenile glaucoma and chromosome 1q in 2 French families. C R Acad Sci III. 1994;317:565–70.PubMed

36.

Morissette J, Cote G, Anctil JL, Plante M, Amyot M, Heon E, et al. A common gene for juvenile and adult-onset primary open-angle glaucomas confined on chromosome 1q. Am J Hum Genet. 1995;56:1431–42.PubMedCentralPubMed

37.

Graff C, Urbak SF, Jerndal T, Wadelius C. Confirmation of linkage to 1q21–31 in a Danish autosomal dominant juvenile-onset glaucoma family and evidence of genetic heterogeneity. Hum Genet. 1995;96:285–9.PubMed

38.

Lichter PR, Richards JE, Boehnke M, Othman M, Cameron BD, Stringham HM, et al. Juvenile glaucoma linked to the GLC1A gene on chromosome 1q in a Panamanian family. Am J Ophthalmol. 1997;123:413–6.PubMed

39.

Johnson AT, Richards JE, Boehnke M, Stringham HM, Herman SB, Wong DJ, et al. Clinical phenotype of juvenile-onset primary open-angle glaucoma linked to chromosome 1q. Ophthalmology. 1996;103:808–14.PubMed

40.

Sunden SL, Alward WL, Nichols BE, Rokhlina TR, Nystuen A, Stone EM, et al. Fine mapping of the autosomal dominant juvenile open angle glaucoma (GLC1A) region and evaluation of candidate genes. Genome Res. 1996;6:862–9.PubMed

41.

Faucher M, Anctil JL, Rodrigue MA, Duchesne A, Bergeron D, Blondeau P, et al. Founder TIGR/myocilin mutations for glaucoma in the Quebec population. Hum Mol Genet. 2002;11:2077–90.PubMed

42.

Shimizu S, Lichter PR, Johnson AT, Zhou Z, Higashi M, Gottfredsdottir M, et al. Age-dependent prevalence of mutations at the GLC1A locus in primary open-angle glaucoma. Am J Ophthalmol. 2000;130:165–77.PubMed

43.

Wiggs JL, Allingham RR, Vollrath D, Jones KH, De La Paz M, Kern J, et al. Prevalence of mutations in TIGR/myocilin in patients with adult and juvenile primary open-angle glaucoma. Am J Hum Genet. 1998;63:1549–52.PubMedCentralPubMed

44.

Fingert JH, Heon E, Liebmann JM, Yamamoto T, Craig JE, Rait J, et al. Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum Mol Genet. 1999;8:899–905.PubMed

45.

Suzuki Y, Shirato S, Taniguchi F, Ohara K, Nishimaki K, Ohta S. Mutations in the TIGR gene in familial primary open-angle glaucoma in Japan. Am J Hum Genet. 1997;61:1202–4.PubMedCentralPubMed

46.

Yoon SJ, Kim HS, Moon JI, Lim JM, Joo CK. Mutations of the TIGR/MYOC gene in primary open-angle glaucoma in Korea. Am J Hum Genet. 1999;64:1775–8.PubMedCentralPubMed

47.

Lam DS, Leung YF, Chua JK, Baum L, Fan DS, Choy KW, et al. Truncations in the TIGR gene in individuals with and without primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2000;41:1386–91.PubMed

48.

Hewitt AW, Mackey DA, Craig JE. Myocilin allele-specific glaucoma phenotype database. Hum Mutat. 2008;29:207–11.PubMed

49.

Adam MF, Belmouden A, Binisti P, Brezin AP, Valtot F, Bechetoille A, et al. Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma. Hum Mol Genet. 1997;6:2091–7.PubMed

50.

Rozsa FW, Shimizu S, Lichter PR, Johnson AT, Othman MI, Scott K, et al. GLC1A mutations point to regions of potential functional importance on the TIGR/MYOC protein. Mol Vis. 1998;4:20.PubMed

51.

Graul TA, Kwon YH, Zimmerman MB, Kim CS, Sheffield VC, Stone EM, et al. A case–control comparison of the clinical characteristics of glaucoma and ocular hypertensive patients with and without the myocilin Gln368Stop mutation. Am J Ophthalmol. 2002;134:884–90.PubMed

52.

Allingham RR, Wiggs JL, De La Paz MA, Vollrath D, Tallett DA, Broomer B, et al. Gln368STOP myocilin mutation in families with late-onset primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 1998;39:2288–95.PubMed

53.

Fingert JH, Ying L, Swiderski RE, Nystuen AM, Arbour NC, Alward WL, et al. Characterization and comparison of the human and mouse GLC1A glaucoma genes. Genome Res. 1998;8:377–84.PubMed

54.

Tamm ER. Myocilin and glaucoma: facts and ideas. Prog Retin Eye Res. 2002;21:395–428.PubMed

55.

Kim BS, Savinova OV, Reedy MV, Martin J, Lun Y, Gan L, et al. Targeted disruption of the myocilin gene (Myoc) suggests that human glaucoma-causing mutations are gain of function. Mol Cell Biol. 2001;21:7707–13.PubMedCentralPubMed

56.

Wiggs JL, Vollrath D. Molecular and clinical evaluation of a patient hemizygous for TIGR/MYOC. Arch Ophthalmol. 2001;119:1674–8.PubMed

57.

Gould DB, Miceli-Libby L, Savinova OV, Torrado M, Tomarev SI, Smith RS, et al. Genetically increasing Myoc expression supports a necessary pathologic role of abnormal proteins in glaucoma. Mol Cell Biol. 2004;24:9019–25.PubMedCentralPubMed

58.

Sohn S, Hur W, Choi YR, Chung YS, Ki CS, Kee C. Little evidence for association of the glaucoma gene MYOC with open-angle glaucoma. Br J Ophthalmol. 2010;94:639–42.PubMedCentralPubMed

59.

He Y, Leung KW, Zhuo YH, Ge J. Pro370Leu mutant myocilin impairs mitochondrial functions in human trabecular meshwork cells. Mol Vis. 2009;15:815–25.PubMed

60.

Gemenetzi M, Yang Y, Lotery AJ. Current concepts on primary open-angle glaucoma genetics: a contribution to disease pathophysiology and future treatment. Eye (London). 2012;26:355–69.

61.

Jacobson N, Andrews M, Shepard AR, Nishimura D, Searby C, Fingert JH, et al. Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor. Hum Mol Genet. 2001;10:117–25.PubMed

62.

Liu Y, Vollrath D. Reversal of mutant myocilin non-secretion and cell killing: implications for glaucoma. Hum Mol Genet. 2004;13:1193–204.PubMed

63.

Yam GH, Gaplovska-Kysela K, Zuber C, Roth J. Aggregated myocilin induces Russell bodies and causes apoptosis: implications for the pathogenesis of myocilin-caused primary open-angle glaucoma. Am J Pathol. 2007;170:100–9.PubMed

64.

Joe MK, Sohn S, Hur W, Moon Y, Choi YR, Kee C. Accumulation of mutant myocilins in ER leads to ER stress and potential cytotoxicity in human trabecular meshwork cells. Biochem Biophys Res Commun. 2003;312:592–600.PubMed

65.

Zode GS, Kuehn MH, Nishimura DY, Searby CC, Mohan K, Grozdanic SD, et al. Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma. J Clin Invest. 2011;121:3542–53.PubMedCentralPubMed

66.

Shepard AR, Jacobson N, Millar JC, Pang IH, Steely HT, Searby CC, et al. Glaucoma-causing myocilin mutants require the peroxisomal targeting signal-1 receptor (PTS1R) to elevate intraocular pressure. Hum Mol Genet. 2007;16:609–17.PubMed

67.

Stoilova D, Child A, Trifan OC, Crick RP, Coakes RL, Sarfarazi M. Localization of a locus (GLC1B) for adult-onset primary open angle glaucoma to the 2cen-q13 region. Genomics. 1996;36:142–50.PubMed

68.

Akiyama M, Yatsu K, Ota M, Katsuyama Y, Kashiwagi K, Mabuchi F, et al. Microsatellite analysis of the GLC1B locus on chromosome 2 points to NCK2 as a new candidate gene for normal tension glaucoma. Br J Ophthalmol. 2008;92:1293–6.PubMed

69.

Shi D, Funayama T, Mashima Y, Takano Y, Shimizu A, Yamamoto K, et al. Association of HK2 and NCK2 with normal tension glaucoma in the Japanese population. PLoS One. 2013;8:e54115.PubMedCentralPubMed

70.

Wirtz MK, Samples JR, Kramer PL, Rust K, Topinka JR, Yount J, et al. Mapping a gene for adult-onset primary open-angle glaucoma to chromosome 3q. Am J Hum Genet. 1997;60:296–304.PubMedCentralPubMed

71.

Kitsos G, Eiberg H, Economou-Petersen E, Wirtz MK, Kramer PL, Aspiotis M, et al. Genetic linkage of autosomal dominant primary open angle glaucoma to chromosome 3q in a Greek pedigree. Eur J Hum Genet. 2001;9:452–7.PubMed

72.

Petersen MB, Kitsos G, Samples JR, Gaudette ND, Economou-Petersen E, Sykes R, et al. A large GLC1C Greek family with a myocilin T377M mutation: inheritance and phenotypic variability. Invest Ophthalmol Vis Sci. 2006;47:620–5.PubMed

73.

Trifan OC, Traboulsi EI, Stoilova D, Alozie I, Nguyen R, Raja S, et al. A third locus (GLC1D) for adult-onset primary open-angle glaucoma maps to the 8q23 region. Am J Ophthalmol. 1998;126:17–28.PubMed

74.

Sarfarazi M, Child A, Stoilova D, Brice G, Desai T, Trifan OC, et al. Localization of the fourth locus (GLC1E) for adult-onset primary open-angle glaucoma to the 10p15–p14 region. Am J Hum Genet. 1998;62:641–52.PubMedCentralPubMed

75.

Alward WL, Kwon YH, Kawase K, Craig JE, Hayreh SS, Johnson AT, et al. Evaluation of optineurin sequence variations in 1,048 patients with open-angle glaucoma. Am J Ophthalmol. 2003;136:904–10.PubMed

76.

Aung T, Ebenezer ND, Brice G, Child AH, Prescott Q, Lehmann OJ, et al. Prevalence of optineurin sequence variants in adult primary open angle glaucoma: implications for diagnostic testing. J Med Genet. 2003;40:e101.PubMed

77.

Ayala-Lugo RM, Pawar H, Reed DM, Lichter PR, Moroi SE, Page M, et al. Variation in optineurin (OPTN) allele frequencies between and within populations. Mol Vis. 2007;13:151–63.PubMed

78.

Caixeta-Umbelino C, de Vasconcellos JP, Costa VP, Kasahara N, Della Paolera M, de Almeida GV, et al. Lack of association between optineurin gene variants T34T, E50K, M98K, 691_692insAG and R545Q and primary open angle glaucoma in Brazilian patients. Ophthalmic Genet. 2009;30:13–8.PubMed

79.

Fuse N, Takahashi K, Akiyama H, Nakazawa T, Seimiya M, Kuwahara S, et al. Molecular genetic analysis of optineurin gene for primary open-angle and normal tension glaucoma in the Japanese population. J Glaucoma. 2004;13:299–303.PubMed

80.

Jansson M, Wadelius C, Rezaie T, Sarfarazi M. Analysis of rare variants and common haplotypes in the optineurin gene in Swedish glaucoma cases. Ophthalmic Genet. 2005;26:85–9.PubMed

81.

McDonald KK, Abramson K, Beltran MA, Ramirez MG, Alvarez M, Ventura A, et al. Myocilin and optineurin coding variants in Hispanics of Mexican descent with POAG. J Hum Genet. 2010;55:697–700.PubMedCentralPubMed

82.

Toda Y, Tang S, Kashiwagi K, Mabuchi F, Iijima H, Tsukahara S, et al. Mutations in the optineurin gene in Japanese patients with primary open-angle glaucoma and normal tension glaucoma. Am J Med Genet A. 2004;125A:1–4.PubMed

83.

Umeda T, Matsuo T, Nagayama M, Tamura N, Tanabe Y, Ohtsuki H. Clinical relevance of optineurin sequence alterations in Japanese glaucoma patients. Ophthalmic Genet. 2004;25:91–9.PubMed

84.

Weisschuh N, Neumann D, Wolf C, Wissinger B, Gramer E. Prevalence of myocilin and optineurin sequence variants in German normal tension glaucoma patients. Mol Vis. 2005;11:284–7.PubMed

85.

Chi ZL, Akahori M, Obazawa M, Minami M, Noda T, Nakaya N, et al. Overexpression of optineurin E50K disrupts Rab8 interaction and leads to a progressive retinal degeneration in mice. Hum Mol Genet. 2010;19:2606–15.PubMed

86.

Hauser MA, Sena DF, Flor J, Walter J, Auguste J, Larocque-Abramson K, et al. Distribution of optineurin sequence variations in an ethnically diverse population of low-tension glaucoma patients from the United States. J Glaucoma. 2006;15:358–63.PubMed

87.

Aung T, Rezaie T, Okada K, Viswanathan AC, Child AH, Brice G, et al. Clinical features and course of patients with glaucoma with the E50K mutation in the optineurin gene. Invest Ophthalmol Vis Sci. 2005;46:2816–22.PubMed

88.

Wiggs JL, Auguste J, Allingham RR, Flor JD, Pericak-Vance MA, Rogers K, et al. Lack of association of mutations in optineurin with disease in patients with adult-onset primary open-angle glaucoma. Arch Ophthalmol. 2003;121:1181–3.PubMedCentralPubMed

89.

Mukhopadhyay A, Komatireddy S, Acharya M, Bhattacharjee A, Mandal AK, Thakur SK, et al. Evaluation of optineurin as a candidate gene in Indian patients with primary open angle glaucoma. Mol Vis. 2005;11:792–7.PubMed

90.

Leung YF, Fan BJ, Lam DS, Lee WS, Tam PO, Chua JK, et al. Different optineurin mutation pattern in primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2003;44:3880–4.PubMed

91.

Cheng JW, Li P, Wei RL. Meta-analysis of association between optineurin gene and primary open-angle glaucoma. Med Sci Monit. 2010;16:CR369–77.PubMed

92.

Ying H, Yue BY. Cellular and molecular biology of optineurin. Int Rev Cell Mol Biol. 2012;294:223–58.PubMedCentralPubMed

93.

Li H, Ao X, Jia J, Wang Q, Zhang Z. Effects of optineurin siRNA on apoptotic genes and apoptosis in RGC-5 cells. Mol Vis. 2011;17:3314–25.PubMed

94.

De Marco N, Buono M, Troise F, Diez-Roux G. Optineurin increases cell survival and translocates to the nucleus in a Rab8-dependent manner upon an apoptotic stimulus. J Biol Chem. 2006;281:16147–56.PubMed

95.

Chalasani ML, Radha V, Gupta V, Agarwal N, Balasubramanian D, Swarup G. A glaucoma-associated mutant of optineurin selectively induces death of retinal ganglion cells which is inhibited by antioxidants. Invest Ophthalmol Vis Sci. 2007;48:1607–14.PubMed

96.

Meng Q, Lv J, Ge H, Zhang L, Xue F, Zhu Y, et al. Overexpressed mutant optineurin (E50K) induces retinal ganglion cells apoptosis via the mitochondrial pathway. Mol Biol Rep. 2012;39:5867–73.PubMed

97.

Sirohi K, Chalasani ML, Sudhakar C, Kumari A, Radha V, Swarup G. M98K-OPTN induces transferrin receptor degradation and RAB12-mediated autophagic death in retinal ganglion cells. Autophagy. 2013;9:510–27.PubMed

98.

Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465:223–6.PubMed

99.

Albagha OM, Visconti MR, Alonso N, Langston AL, Cundy T, Dargie R, et al. Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget’s disease of bone. Nat Genet. 2010;42:520–4.PubMedCentralPubMed

100.

Wirtz MK, Samples JR, Rust K, Lie J, Nordling L, Schilling K, et al. GLC1F, a new primary open-angle glaucoma locus, maps to 7q35–q36. Arch Ophthalmol. 1999;117:237–41.PubMed

101.

Pasutto F, Keller KE, Weisschuh N, Sticht H, Samples JR, Yang YF, et al. Variants in ASB10 are associated with open-angle glaucoma. Hum Mol Genet. 2012;21:1336–49.PubMed

102.

Fingert JH, Roos BR, Solivan-Timpe F, Miller KA, Oetting TA, Wang K, et al. Analysis of ASB10 variants in open angle glaucoma. Hum Mol Genet. 2012;21:4543–8.PubMed

103.

Murakami K, Meguro A, Ota M, Shiota T, Nomura N, Kashiwagi K, et al. Analysis of microsatellite polymorphisms within the GLC1F locus in Japanese patients with normal tension glaucoma. Mol Vis. 2010;16:462–6.PubMed

104.

Hauser MA, Allingham RR, Linkroum K, Wang J, LaRocque-Abramson K, Figueiredo D, et al. Distribution of WDR36 DNA sequence variants in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2006;47:2542–6.PubMed

105.

Frezzotti P, Pescucci C, Papa FT, Iester M, Mittica V, Motolese I, et al. Association between primary open-angle glaucoma (POAG) and WDR36 sequence variance in Italian families affected by POAG. Br J Ophthalmol. 2011;95:624–6.PubMed

106.

Pasutto F, Mardin CY, Michels-Rautenstrauss K, Weber BH, Sticht H, Chavarria-Soley G, et al. Profiling of WDR36 missense variants in German patients with glaucoma. Invest Ophthalmol Vis Sci. 2008;49:270–4.PubMed

107.

Fan BJ, Wang DY, Cheng CY, Ko WC, Lam SC, Pang CP. Different WDR36 mutation pattern in Chinese patients with primary open-angle glaucoma. Mol Vis. 2009;15:646–53.PubMed

108.

Mookherjee S, Chakraborty S, Vishal M, Banerjee D, Sen A, Ray K. WDR36 variants in East Indian primary open-angle glaucoma patients. Mol Vis. 2011;17:2618–27.PubMed

109.

Weisschuh N, Wolf C, Wissinger B, Gramer E. Variations in the WDR36 gene in German patients with normal tension glaucoma. Mol Vis. 2007;13:724–9.PubMed

110.

Miyazawa A, Fuse N, Mengkegale M, Ryu M, Seimiya M, Wada Y, et al. Association between primary open-angle glaucoma and WDR36 DNA sequence variants in Japanese. Mol Vis. 2007;13:1912–9.PubMed

111.

Fingert JH, Alward WL, Kwon YH, Shankar SP, Andorf JL, Mackey DA, et al. No association between variations in the WDR36 gene and primary open-angle glaucoma. Arch Ophthalmol. 2007;125:434–6.PubMed

112.

Skarie JM, Link BA. The primary open-angle glaucoma gene WDR36 functions in ribosomal RNA processing and interacts with the p53 stress-response pathway. Hum Mol Genet. 2008;17:2474–85.PubMed

113.

Footz TK, Johnson JL, Dubois S, Boivin N, Raymond V, Walter MA. Glaucoma-associated WDR36 variants encode functional defects in a yeast model system. Hum Mol Genet. 2009;18:1276–87.PubMed

114.

Chi ZL, Yasumoto F, Sergeev Y, Minami M, Obazawa M, Kimura I, et al. Mutant WDR36 directly affects axon growth of retinal ganglion cells leading to progressive retinal degeneration in mice. Hum Mol Genet. 2010;19:3806–15.PubMed

115.

Suriyapperuma SP, Child A, Desai T, Brice G, Kerr A, Crick RP, et al. A new locus (GLC1H) for adult-onset primary open-angle glaucoma maps to the 2p15–p16 region. Arch Ophthalmol. 2007;125:86–92.PubMed

116.

Lin Y, Liu T, Li J, Yang J, Du Q, Wang J, et al. A genome-wide scan maps a novel autosomal dominant juvenile-onset open-angle glaucoma locus to 2p15–16. Mol Vis. 2008;14:739–44.PubMed

117.

Jiao X, Yang Z, Yang X, Chen Y, Tong Z, Zhao C, et al. Common variants on chromosome 2 and risk of primary open-angle glaucoma in the Afro-Caribbean population of Barbados. Proc Natl Acad Sci USA. 2009;106:17105–10.PubMed

118.

Liu Y, Qin X, Schmidt S, Allingham RR, Hauser MA. Association between chromosome 2p16.3 variants and glaucoma in populations of African descent. Proc Natl Acad Sci USA. 2010;107:E61 (author reply E2).PubMed

119.

Duggal P, Klein AP, Lee KE, Klein R, Klein BE, Bailey-Wilson JE. The GLC1H glaucoma locus may reflect glaucoma with elevated intraocular pressure. Arch Ophthalmol. 2007;125:1716–7 (author reply 7).PubMed

120.

Allingham RR, Wiggs JL, Hauser ER, Larocque-Abramson KR, Santiago-Turla C, Broomer B, et al. Early adult-onset POAG linked to 15q11–13 using ordered subset analysis. Invest Ophthalmol Vis Sci. 2005;46:2002–5.PubMedCentralPubMed

121.

Wiggs JL, Lynch S, Ynagi G, Maselli M, Auguste J, Del Bono EA, et al. A genomewide scan identifies novel early-onset primary open-angle glaucoma loci on 9q22 and 20p12. Am J Hum Genet. 2004;74:1314–20.PubMedCentralPubMed

122.

Sud A, Del Bono EA, Haines JL, Wiggs JL. Fine mapping of the GLC1K juvenile primary open-angle glaucoma locus and exclusion of candidate genes. Mol Vis. 2008;14:1319–26.PubMed

123.

Craig JE, Baird PN, Healey DL, McNaught AI, McCartney PJ, Rait JL, et al. Evidence for genetic heterogeneity within eight glaucoma families, with the GLC1A Gln368STOP mutation being an important phenotypic modifier. Ophthalmology. 2001;108:1607–20.PubMed

124.

Wang DY, Fan BJ, Canlas O, Tam PO, Ritch R, Lam DS, et al. Absence of myocilin and optineurin mutations in a large Philippine family with juvenile onset primary open angle glaucoma. Mol Vis. 2004;10:851–6.PubMed

125.

Fan BJ, Ko WC, Wang DY, Canlas O, Ritch R, Lam DS, et al. Fine mapping of new glaucoma locus GLC1M and exclusion of neuregulin 2 as the causative gene. Mol Vis. 2007;13:779–84.PubMed

126.

Liu Y, Liu W, Crooks K, Schmidt S, Allingham RR, Hauser MA. No evidence of association of heterozygous NTF4 mutations in patients with primary open-angle glaucoma. Am J Hum Genet. 2010;86:498–9 (author reply 500).PubMedCentralPubMed

127.

Rao KN, Kaur I, Parikh RS, Mandal AK, Chandrasekhar G, Thomas R, et al. Variations in NTF4, VAV2, and VAV3 genes are not involved with primary open-angle and primary angle-closure glaucomas in an Indian population. Invest Ophthalmol Vis Sci. 2010;51:4937–41.PubMed

128.

Vithana EN, Nongpiur ME, Venkataraman D, Chan SH, Mavinahalli J, Aung T. Identification of a novel mutation in the NTF4 gene that causes primary open-angle glaucoma in a Chinese population. Mol Vis. 2010;16:1640–5.PubMed

129.

Chen LJ, Ng TK, Fan AH, Leung DY, Zhang M, Wang N, et al. Evaluation of NTF4 as a causative gene for primary open-angle glaucoma. Mol Vis. 2012;18:1763–72.PubMed

130.

Morton S, Hesson L, Peggie M, Cohen P. Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma. FEBS Lett. 2008;582:997–1002.PubMed

131.

Kawase K, Allingham RR, Meguro A, Mizuki N, Roos B, Solivan-Timpe FM, et al. Confirmation of TBK1 duplication in normal tension glaucoma. Exp Eye Res. 2012;96:178–80.PubMedCentralPubMed

132.

Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA. 2009;106:9362–7.PubMed

133.

Meguro A, Inoko H, Ota M, Mizuki N, Bahram S. Genome-wide association study of normal tension glaucoma: common variants in SRBD1 and ELOVL5 contribute to disease susceptibility. Ophthalmology. 2010;117(1331–8):e5.PubMed

134.

Mabuchi F, Sakurada Y, Kashiwagi K, Yamagata Z, Iijima H, Tsukahara S. Association between SRBD1 and ELOVL5 gene polymorphisms and primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2011;52:4626–9.PubMed

135.

Gibson J, Griffiths H, De Salvo G, Cole M, Jacob A, Macleod A, et al. Genome-wide association study of primary open angle glaucoma risk and quantitative traits. Mol Vis. 2012;18:1083–92.PubMed

136.

Thorleifsson G, Walters GB, Hewitt AW, Masson G, Helgason A, DeWan A, et al. Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma. Nat Genet. 2010;42:906–9.PubMedCentralPubMed

137.

Wiggs JL, Kang JH, Yaspan BL, Mirel DB, Laurie C, Crenshaw A, et al. Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma in Caucasians from the USA. Hum Mol Genet. 2011;20:4707–13.PubMed

138.

Abu-Amero KK, Kondkar AA, Mousa A, Osman EA, Al-Obeidan SA. Lack of association of SNP rs4236601 near CAV1 and CAV2 with POAG in a Saudi cohort. Mol Vis. 2012;18:1960–5.PubMed

139.

Kuehn MH, Wang K, Roos B, Stone EM, Kwon YH, Alward WL, et al. Chromosome 7q31 POAG locus: ocular expression of caveolins and lack of association with POAG in a US cohort. Mol Vis. 2011;17:430–5.PubMed

140.

Burdon KP, Macgregor S, Hewitt AW, Sharma S, Chidlow G, Mills RA, et al. Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1. Nat Genet. 2011;43:574–8.PubMed

141.

van Koolwijk LM, Ramdas WD, Ikram MK, Jansonius NM, Pasutto F, Hysi PG, et al. Common genetic determinants of intraocular pressure and primary open-angle glaucoma. PLoS Genet. 2012;8:e1002611.PubMedCentralPubMed

142.

Sharma S, Burdon KP, Chidlow G, Klebe S, Crawford A, Dimasi DP, et al. Association of genetic variants in the TMCO1 gene with clinical parameters related to glaucoma and characterization of the protein in the eye. Invest Ophthalmol Vis Sci. 2012;53:4917–25.PubMed

143.

Nakano M, Ikeda Y, Tokuda Y, Fuwa M, Omi N, Ueno M, et al. Common variants in CDKN2B-AS1 associated with optic-nerve vulnerability of glaucoma identified by genome-wide association studies in Japanese. PLoS One. 2012;7:e33389.PubMedCentralPubMed

144.

Osman W, Low SK, Takahashi A, Kubo M, Nakamura Y. A genome-wide association study in the Japanese population confirms 9p21 and 14q23 as susceptibility loci for primary open angle glaucoma. Hum Mol Genet. 2012;21:2836–42.PubMed

145.

Takamoto M, Kaburaki T, Mabuchi A, Araie M, Amano S, Aihara M, et al. Common variants on chromosome 9p21 are associated with normal tension glaucoma. PLoS One. 2012;7:e40107.PubMedCentralPubMed

146.

Wiggs JL, Yaspan BL, Hauser MA, Kang JH, Allingham RR, Olson LM, et al. Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma. PLoS Genet. 2012;8:e1002654.PubMedCentralPubMed

147.

Fan BJ, Wang DY, Pasquale LR, Haines JL, Wiggs JL. Genetic variants associated with optic nerve vertical cup-to-disc ratio are risk factors for primary open angle glaucoma in a US Caucasian population. Invest Ophthalmol Vis Sci. 2011;52:1788–92.PubMed

148.

Mabuchi F, Sakurada Y, Kashiwagi K, Yamagata Z, Iijima H, Tsukahara S. Association between genetic variants associated with vertical cup-to-disc ratio and phenotypic features of primary open-angle glaucoma. Ophthalmology. 2012;119:1819–25.PubMed

149.

Cao D, Jiao X, Liu X, Hennis A, Leske MC, Nemesure B, et al. CDKN2B polymorphism is associated with primary open-angle glaucoma (POAG) in the Afro-Caribbean population of Barbados, West Indies. PLoS One. 2012;7:e39278.PubMedCentralPubMed

150.

Ramdas WD, van Koolwijk LM, Ikram MK, Jansonius NM, de Jong PT, Bergen AA, et al. A genome-wide association study of optic disc parameters. PLoS Genet. 2010;6:e1000978.PubMedCentralPubMed

151.

Hannon GJ, Beach D. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature. 1994;371:257–61.PubMed

152.

Duenker N. Transforming growth factor-beta (TGF-beta) and programmed cell death in the vertebrate retina. Int Rev Cytol. 2005;245:17–43.PubMed

153.

Pena JD, Taylor AW, Ricard CS, Vidal I, Hernandez MR. Transforming growth factor beta isoforms in human optic nerve heads. Br J Ophthalmol. 1999;83:209–18.PubMed

154.

Fuchshofer R. The pathogenic role of transforming growth factor-beta2 in glaucomatous damage to the optic nerve head. Exp Eye Res. 2011;93:165–9.PubMed

155.

Trivedi RH, Nutaitis M, Vroman D, Crosson CE. Influence of race and age on aqueous humor levels of transforming growth factor-beta 2 in glaucomatous and nonglaucomatous eyes. J Ocul Pharmacol Ther. 2011;27:477–80.PubMed

156.

Pasmant E, Sabbagh A, Vidaud M, Bieche I. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J. 2011;25:444–8.PubMed

157.

Helgadottir A, Thorleifsson G, Magnusson KP, Gretarsdottir S, Steinthorsdottir V, Manolescu A, et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet. 2008;40:217–24.PubMed

158.

Uno S, Zembutsu H, Hirasawa A, Takahashi A, Kubo M, Akahane T, et al. A genome-wide association study identifies genetic variants in the CDKN2BAS locus associated with endometriosis in Japanese. Nat Genet. 2010;42:707–10.PubMed

159.

Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet. 2009;41:899–904.PubMed

160.

Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, Decker PA, et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet. 2009;41:905–8.PubMedCentralPubMed

161.

Dimasi DP, Burdon KP, Hewitt AW, Fitzgerald J, Wang JJ, Healey PR, et al. Genetic investigation into the endophenotypic status of central corneal thickness and optic disc parameters in relation to open-angle glaucoma. Am J Ophthalmol. 2012;154(833–42):e2.PubMed

162.

Gallardo ME, Lopez-Rios J, Fernaud-Espinosa I, Granadino B, Sanz R, Ramos C, et al. Genomic cloning and characterization of the human homeobox gene SIX6 reveals a cluster of SIX genes in chromosome 14 and associates SIX6 hemizygosity with bilateral anophthalmia and pituitary anomalies. Genomics. 1999;61:82–91.PubMed

163.

Nolen LD, Amor D, Haywood A, St Heaps L, Willcock C, Mihelec M, et al. Deletion at 14q22–23 indicates a contiguous gene syndrome comprising anophthalmia, pituitary hypoplasia, and ear anomalies. Am J Med Genet A. 2006;140:1711–8.PubMed

164.

Juronen E, Tasa G, Veromann S, Parts L, Tiidla A, Pulges R, et al. Polymorphic glutathione S-transferase M1 is a risk factor of primary open-angle glaucoma among Estonians. Exp Eye Res. 2000;71:447–52.PubMed

165.

Rocha AV, Talbot T, Magalhaes da Silva T, Almeida MC, Menezes CA, Di Pietro G, et al. Is the GSTM1 null polymorphism a risk factor in primary open angle glaucoma? Mol Vis. 2011;17:1679–86.PubMed

166.

Aung T, Ocaka L, Ebenezer ND, Morris AG, Krawczak M, Thiselton DL, et al. A major marker for normal tension glaucoma: association with polymorphisms in the OPA1 gene. Hum Genet. 2002;110:52–6.PubMed

167.

Powell BL, Toomes C, Scott S, Yeung A, Marchbank NJ, Spry PG, et al. Polymorphisms in OPA1 are associated with normal tension glaucoma. Mol Vis. 2003;9:460–4.PubMed

168.

Mabuchi F, Tang S, Kashiwagi K, Yamagata Z, Iijima H, Tsukahara S. The OPA1 gene polymorphism is associated with normal tension and high tension glaucoma. Am J Ophthalmol. 2007;143:125–30.PubMed

169.

Yu-Wai-Man P, Stewart JD, Hudson G, Andrews RM, Griffiths PG, Birch MK, et al. OPA1 increases the risk of normal but not high tension glaucoma. J Med Genet. 2010;47:120–5.PubMed

170.

Guo Y, Chen X, Zhang H, Li N, Yang X, Cheng W, et al. Association of OPA1 polymorphisms with NTG and HTG: a meta-analysis. PLoS One. 2012;7:e42387.PubMedCentralPubMed

171.

Vickers JC, Craig JE, Stankovich J, McCormack GH, West AK, Dickinson JL, et al. The apolipoprotein epsilon4 gene is associated with elevated risk of normal tension glaucoma. Mol Vis. 2002;8:389–93.PubMed

172.

Mabuchi F, Tang S, Ando D, Yamakita M, Wang J, Kashiwagi K, et al. The apolipoprotein E gene polymorphism is associated with open angle glaucoma in the Japanese population. Mol Vis. 2005;11:609–12.PubMed

173.

Lin HJ, Tsai FJ, Chen WC, Shi YR, Hsu Y, Tsai SW. Association of tumour necrosis factor alpha −308 gene polymorphism with primary open-angle glaucoma in Chinese. Eye (London). 2003;17:31–4.

174.

Razeghinejad MR, Rahat F, Kamali-Sarvestani E. Association of TNFA −308 G/A and TNFRI +36 A/G gene polymorphisms with glaucoma. Ophthalmic Res. 2009;42:118–24.PubMed

175.

Fan BJ, Liu K, Wang DY, Tham CC, Tam PO, Lam DS, et al. Association of polymorphisms of tumor necrosis factor and tumor protein p53 with primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2010;51:4110–6.PubMed

176.

Bozkurt B, Mesci L, Irkec M, Ozdag BB, Sanal O, Arslan U, et al. Association of tumour necrosis factor-alpha −308 G/A polymorphism with primary open-angle glaucoma. Clin Exp Ophthalmol. 2012;40:e156–62.

177.

Wang CY, Shen YC, Wei LC, Lin KH, Feng SC, Yang YY, et al. Polymorphism in the TNF-alpha (−863) locus associated with reduced risk of primary open angle glaucoma. Mol Vis. 2012;18:779–85.PubMed

178.

Tsai FJ, Lin HJ, Chen WC, Tsai CH, Tsai SW. A codon 31ser-arg polymorphism of the WAF-1/CIP-1/p21/tumour suppressor gene in Chinese primary open-angle glaucoma. Acta Ophthalmol Scand. 2004;82:76–80.PubMed

179.

Lin HJ, Tsai FJ, Hung P, Chen WC, Chen HY, Fan SS, et al. Association of E-cadherin gene 3′-UTR C/T polymorphism with primary open angle glaucoma. Ophthalmic Res. 2006;38:44–8.PubMed

180.

Wang CY, Shen YC, Lo FY, Su CH, Lee SH, Lin KH, et al. Polymorphism in the IL-1alpha (−889) locus associated with elevated risk of primary open angle glaucoma. Mol Vis. 2006;12:1380–5.PubMed

181.

Tosaka K, Mashima Y, Funayama T, Ohtake Y, Kimura I. Association between open-angle glaucoma and gene polymorphism for heat-shock protein 70-1. Jpn J Ophthalmol. 2007;51:417–23.PubMed

182.

Bhattacharjee A, Banerjee D, Mookherjee S, Acharya M, Banerjee A, Ray A, et al. Leu432Val polymorphism in CYP1B1 as a susceptible factor towards predisposition to primary open-angle glaucoma. Mol Vis. 2008;14:841–50.PubMed

183.

Shibuya E, Meguro A, Ota M, Kashiwagi K, Mabuchi F, Iijima H, et al. Association of toll-like receptor 4 gene polymorphisms with normal tension glaucoma. Invest Ophthalmol Vis Sci. 2008;49:4453–7.PubMed

184.

Takano Y, Shi D, Shimizu A, Funayama T, Mashima Y, Yasuda N, et al. Association of toll-like receptor 4 gene polymorphisms in Japanese subjects with primary open-angle, normal-tension, and exfoliation glaucoma. Am J Ophthalmol. 2012;154(825–32):e1.PubMed

185.

Ayub H, Khan MI, Micheal S, Akhtar F, Ajmal M, Shafique S, et al. Association of eNOS and HSP70 gene polymorphisms with glaucoma in Pakistani cohorts. Mol Vis. 2010;16:18–25.PubMed

186.

Liao Q, Wang DH, Sun HJ. Association of genetic polymorphisms of eNOS with glaucoma. Mol Vis. 2011;17:153–8.PubMed

187.

Magalhaes da Silva T, Rocha AV, Lacchini R, Marques CR, Silva ES, Tanus-Santos JE, et al. Association of polymorphisms of endothelial nitric oxide synthase (eNOS) gene with the risk of primary open angle glaucoma in a Brazilian population. Gene. 2012;502:142–6.PubMed

188.

Lin HJ, Chen WC, Tsai FJ, Tsai SW. Distributions of p53 codon 72 polymorphism in primary open angle glaucoma. Br J Ophthalmol. 2002;86:767–70.PubMed

189.

Yousaf S, Khan MI, Micheal S, Akhtar F, Ali SH, Riaz M, et al. XRCC1 and XPD DNA repair gene polymorphisms: a potential risk factor for glaucoma in the Pakistani population. Mol Vis. 2011;17:1153–63.PubMed

190.

Majsterek I, Markiewicz L, Przybylowska K, Gacek M, Kurowska AK, Kaminska A, et al. Association of MMP1-1607 1G/2G and TIMP1 372 T/C gene polymorphisms with risk of primary open angle glaucoma in a Polish population. Med Sci Monit. 2011;17:CR417–21.PubMed

191.

Liu Y, Gibson J, Wheeler J, Kwee LC, Santiago-Turla CM, Akafo SK, et al. GALC deletions increase the risk of primary open-angle glaucoma: the role of Mendelian variants in complex disease. PLoS One. 2011;6:e27134.PubMedCentralPubMed

192.

Zanon-Moreno V, Ciancotti-Olivares L, Asencio J, Sanz P, Ortega-Azorin C, Pinazo-Duran MD, et al. Association between a SLC23A2 gene variation, plasma vitamin C levels, and risk of glaucoma in a Mediterranean population. Mol Vis. 2011;17:2997–3004.PubMed

193.

Zanon-Moreno V, Asensio-Marquez EM, Ciancotti-Oliver L, Garcia-Medina JJ, Sanz P, Ortega-Azorin C, et al. Effects of polymorphisms in vitamin E-, vitamin C-, and glutathione peroxidase-related genes on serum biomarkers and associations with glaucoma. Mol Vis. 2013;19:231–42.PubMed

194.

Bleich S, Junemann A, von Ahsen N, Lausen B, Ritter K, Beck G, et al. Homocysteine and risk of open-angle glaucoma. J Neural Transm. 2002;109:1499–504.PubMed

195.

Junemann AG, von Ahsen N, Reulbach U, Roedl J, Bonsch D, Kornhuber J, et al. C677T variant in the methylentetrahydrofolate reductase gene is a genetic risk factor for primary open-angle glaucoma. Am J Ophthalmol. 2005;139:721–3.PubMed

196.

Burdon KP, Crawford A, Casson RJ, Hewitt AW, Landers J, Danoy P, et al. Glaucoma risk alleles at CDKN2B-AS1 are associated with lower intraocular pressure, normal-tension glaucoma, and advanced glaucoma. Ophthalmology. 2012;119:1539–45.PubMed

197.

Minegishi Y, Iejima D, Kobayashi H, Chi ZL, Kawase K, Yamamoto T, et al. Enhanced optineurin E50K–TBK1 interaction evokes protein insolubility and initiates familial primary open-angle glaucoma. Hum Mol Genet. 2013;22:3559–67.

198.

Weidberg H, Elazar Z. TBK1 mediates crosstalk between the innate immune response and autophagy. Sci Signal. 2011;4:pe39.PubMed

199.

Wild P, Farhan H, McEwan DG, Wagner S, Rogov VV, Brady NR, et al. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science. 2011;333:228–33.PubMedCentralPubMed

200.

Alexander C, Votruba M, Pesch UE, Thiselton DL, Mayer S, Moore A, et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet. 2000;26:211–5.PubMed

201.

Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P, et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet. 2000;26:207–10.PubMed

202.

Yu-Wai-Man P, Griffiths PG, Hudson G, Chinnery PF. Inherited mitochondrial optic neuropathies. J Med Genet. 2009;46:145–58.PubMedCentralPubMed

203.

Luo C, Yang X, Kain AD, Powell DW, Kuehn MH, Tezel G. Glaucomatous tissue stress and the regulation of immune response through glial toll-like receptor signaling. Invest Ophthalmol Vis Sci. 2010;51:5697–707.PubMed

204.

Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001;2:675–80.PubMed

205.

Chen HW, Rainey RN, Balatoni CE, Dawson DW, Troke JJ, Wasiak S, et al. Mammalian polynucleotide phosphorylase is an intermembrane space RNase that maintains mitochondrial homeostasis. Mol Cell Biol. 2006;26:8475–87.PubMedCentralPubMed

206.

Leszczyniecka M, Kang DC, Sarkar D, Su ZZ, Holmes M, Valerie K, et al. Identification and cloning of human polynucleotide phosphorylase, hPNPase old-35, in the context of terminal differentiation and cellular senescence. Proc Natl Acad Sci USA. 2002;99:16636–41.PubMed

207.

Schnier J, Stoffler G, Nishi K. Deletion and insertion mutants in the structural gene for ribosomal protein S1 from Escherichia coli. J Biol Chem. 1986;261:11866–71.PubMed

208.

Sarkar D, Lebedeva IV, Emdad L, Kang DC, Baldwin AS Jr, Fisher PB. Human polynucleotide phosphorylase (hPNPaseold-35): a potential link between aging and inflammation. Cancer Res. 2004;64:7473–8.PubMed

209.

Sarkar D, Leszczyniecka M, Kang DC, Lebedeva IV, Valerie K, Dhar S, et al. Down-regulation of Myc as a potential target for growth arrest induced by human polynucleotide phosphorylase (hPNPaseold-35) in human melanoma cells. J Biol Chem. 2003;278:24542–51.PubMed

210.

Canepa ET, Scassa ME, Ceruti JM, Marazita MC, Carcagno AL, Sirkin PF, et al. INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions. IUBMB Life. 2007;59:419–26.PubMed

211.

Greene LA, Liu DX, Troy CM, Biswas SC. Cell cycle molecules define a pathway required for neuron death in development and disease. Biochim Biophys Acta. 2007;1772:392–401.PubMedCentralPubMed

212.

Hashimoto M, Masliah E. Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer’s and dementia with Lewy bodies. Neurochem Res. 2003;28:1743–56.PubMed

213.

Hashimoto M, Takenouchi T, Rockenstein E, Masliah E. Alpha-synuclein up-regulates expression of caveolin-1 and down-regulates extracellular signal-regulated kinase activity in B103 neuroblastoma cells: role in the pathogenesis of Parkinson’s disease. J Neurochem. 2003;85:1468–79.PubMed

214.

Surgucheva I, Park BC, Yue BY, Tomarev S, Surguchov A. Interaction of myocilin with gamma-synuclein affects its secretion and aggregation. Cell Mol Neurobiol. 2005;25:1009–33.PubMed

215.

Surgucheva I, Weisman AD, Goldberg JL, Shnyra A, Surguchov A. Gamma-synuclein as a marker of retinal ganglion cells. Mol Vis. 2008;14:1540–8.PubMed

216.

Surgucheva I, Shestopalov VI, Surguchov A. Effect of gamma-synuclein silencing on apoptotic pathways in retinal ganglion cells. J Biol Chem. 2008;283:36377–85.PubMed

Titel: Genetics of primary open angle glaucoma
verfasst von: Mitsuko Takamoto
Makoto Araie
Publikationsdatum: 01.01.2014
Verlag: Springer Japan
Erschienen in: Japanese Journal of Ophthalmology / Ausgabe 1/2014
Print ISSN: 0021-5155
Elektronische ISSN: 1613-2246
DOI: https://doi.org/10.1007/s10384-013-0286-0

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Genetics of primary open angle glaucoma

Abstract

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2014

Persistence with topical glaucoma therapy among newly diagnosed Japanese patients

Clinical course of patients with Behçet’s uveitis following discontinuation of infliximab therapy

Myopia and diabetes mellitus as modificatory factors of glaucomatous optic neuropathy

Outcome of conventional treatment for adult amblyopia

Evaluation of peripapillary choroidal thickness in unilateral normal-tension glaucoma

Comparison of 2007–2012 Korean trends in laser peripheral iridotomy and cataract surgery rates

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde